Candidate gene
Marker
| may function as a novel tumor marker, and a prospective prognostic indicator for cervical cancer | Therapy target
|
System | Type | Disorder | Pubmed |
respiratory | CF (mucoviscidosis) | | |
ion channel modulating agents, such as lancovutide (Moli1901, duramycin) and denufosol, which activate alternate (non-CF transmembrane regulator [CFTR]) chloride channels, and GS 9411, a sodium channel antagonist, are now at the stages of clinical study a | cancer | reproductive | uterus | |
may function as a potential therapeutic target for cervical cancer |
| | |